HIGHLIGHTS
- who: Maisa S. Ziadni et al. from the Study design and oversight This uncontrolled, prospective trial was coordinated by Stanford University School of Medicine and had class leaders and patients from both the local area and various statesThe study protocol was approved by the Stanford University Institutional Review Board (IRB), and electronic consent was obtained from all participants. We utilized an iterative development approach in which we first conducted an initial pilot class with , participants, after which we improved procedures and finalized study slides and protocols for the uncontrolled trial. The trial was then registered with(NCT05014126 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.